Dihydromyricetin Reverses Thioacetamide-Induced Liver Fibrosis Through Inhibiting NF-κB-Mediated Inflammation and TGF-β1-Regulated of PI3K/Akt Signaling Pathway

As a natural active substance, dihydromyricetin (DHM) has been proven to have good hepatoprotective activity. However, the therapeutic effect of DHM on liver fibrosis, which has become a liver disease threatening the health of people around the world, has not been studied to date. The purpose of thi...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Yingchun Zhao, Xinglong Liu, Chuanbo Ding, Yan Gu, Wencong Liu
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2021-11-01
Edice:	Frontiers in Pharmacology
Témata:	dihydromyricetin liver fibrosis NF-κB signaling pathway inflammation hepatic stellate cell activation anti-apoptosis
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fphar.2021.783886/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!